Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hyatt

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Soft Matter|February 5, 2015
Ultrasoft, highly deformable microgelsHaylee Bachman, Ashley C Brown, Kimberly C Clarke, et al.
Urologic Oncology|October 13, 2014
Income inequality and treatment of African American men with high-risk prostate cancerDavid R Ziehr, Brandon A Mahal, Ayal A Aizer, et al.
Urology|April 15, 2014
Weight gain on androgen deprivation therapy: which patients are at highest risk?Daniel M Seible, Xiangmei Gu, Andrew S Hyatt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2014
Incidence and determinants of 1-month mortality after cancer-directed surgeryB A Mahal, G Inverso, A A Aizer, et al.
Brachytherapy|June 2, 2014
Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term resultsBrandon A Mahal, David R Ziehr, Andrew S Hyatt, et al.
Clinical Genitourinary Cancer|May 28, 2014
Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancerBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Prostate Cancer and Prostatic Diseases|July 2, 2014
The association between insurance status and prostate cancer outcomes: implications for the Affordable Care ActB A Mahal, A A Aizer, D R Ziehr, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Soft Matter|February 5, 2015
Ultrasoft, highly deformable microgelsHaylee Bachman, Ashley C Brown, Kimberly C Clarke, et al.
Urologic Oncology|October 13, 2014
Income inequality and treatment of African American men with high-risk prostate cancerDavid R Ziehr, Brandon A Mahal, Ayal A Aizer, et al.
Urology|April 15, 2014
Weight gain on androgen deprivation therapy: which patients are at highest risk?Daniel M Seible, Xiangmei Gu, Andrew S Hyatt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2014
Incidence and determinants of 1-month mortality after cancer-directed surgeryB A Mahal, G Inverso, A A Aizer, et al.
Brachytherapy|June 2, 2014
Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term resultsBrandon A Mahal, David R Ziehr, Andrew S Hyatt, et al.
Clinical Genitourinary Cancer|May 28, 2014
Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancerBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Prostate Cancer and Prostatic Diseases|July 2, 2014
The association between insurance status and prostate cancer outcomes: implications for the Affordable Care ActB A Mahal, A A Aizer, D R Ziehr, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Pageof 10